Many babies who develop bronchopulmonary dysplasia (BPD) are born with serious respiratory distress syndrome (RDS). The signs and symptoms of RDS at birth are:
Babies who have RDS are treated with surfactant replacement therapy. They also may need oxygen therapy (oxygen given through nasal prongs, a mask, or a breathing tube).
Shortly after birth, some babies who have RDS also are treated with nasal continuous positive airway pressure (NCPAP) or ventilators (machines that support breathing).
Often, the symptoms of RDS start to improve slowly after about a week. However, some babies get worse and need more oxygen or breathing support from NCPAP or a ventilator.
A first sign of BPD is when premature infants—usually those born more than 10 weeks early—still need oxygen therapy by the time they reach their original due dates. These babies are diagnosed with BPD.
Infants who have severe BPD may have trouble feeding, which can lead to delayed growth. These babies also may develop:
Clinical trials are research studies that explore whether a medical strategy, treatment, or device is safe and effective for humans. To find clinical trials that are currently underway for Bronchopulmonary Dysplasia, visit www.clinicaltrials.gov.
![]()
Visit Children and Clinical Studies to hear experts, parents, and children talk about their experiences with clinical research.
The NHLBI updates Health Topics articles on a biennial cycle based on a thorough review of research findings and new literature. The articles also are updated as needed if important new research is published. The date on each Health Topics article reflects when the content was originally posted or last revised.